Raman Singh

CEO at Juniper Biologics
  • Claim this Profile
Contact Information
Location
SG

Topline Score

Bio

Generated by
Topline AI

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content. Click here to join now

Experience

    • Singapore
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • CEO
      • Nov 2020 - 3 years 2 months
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • CEO
      • 2011 - Nov 2020

      Singapore • Reporting to the Board of Mundipharma and responsible for all areas of the business • Leading an integrated organization comprising Commercial, Research & Development, Regulatory, Medical Affairs, Corporate Communication, Manufacturing, Supply Chain, Business Development, Legal & Compliance Highlights • Mundipharma has become the fastest growing Pharmaceutical Company in Emerging markets achieving 26 consecutive quarters of growth resulting in annual sales of over $3B (USD)… Show more • Reporting to the Board of Mundipharma and responsible for all areas of the business • Leading an integrated organization comprising Commercial, Research & Development, Regulatory, Medical Affairs, Corporate Communication, Manufacturing, Supply Chain, Business Development, Legal & Compliance Highlights • Mundipharma has become the fastest growing Pharmaceutical Company in Emerging markets achieving 26 consecutive quarters of growth resulting in annual sales of over $3B (USD). • Built an organization of approximately 350 people in 2011 to over 10,000 people in 2018. • Geographically expanding the footprint in Asia including China, Latin America and Middle East & Africa and delivering Mundipharma as a strong global player in the Pharmaceutical space. This has meant having the right infrastructure, portfolio and access. • Increased the number of medicines the organisation provides from 10 in one therapeutic area to over 50 in a range diversified therapeutic areas. • Transformed the business through rapid organic and inorganic growth; successfully completed over 50 in-licensing/acquisition deals across multiple therapy areas • Building talent to manage expansion, including guiding the organisation towards a number of Employer of Choice awards in a range of countries. • Developed a corporate culture around innovation, entrepreneurism and execution. Successfully positioned Mundipharma as a unique pharmaceutical company and created a culture which is highly admired by employees • Featured as a thought leader for Financial Times, Wall Street Journal, CNBC, Bloomberg, BBC, CNN, Economist and other international media outlets. Show less

    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Vice President Commercial Operations – Emerging Markets & Asia-Pacific
      • 2008 - 2011

      London, United Kingdom • Headed Commercial Operations for the region with a turnover of £5 bn. The region included Asia Pacific plus China, South Asia, Middle-East, Africa, CIS, Mexico & South America • Created a diversified business, organically and inorganically, moving from just being an Innovative Brand Company to include Classic Brands & Dermatology Highlights • In two years, achieved sales growth of 50% and a trading profit growth of 47% within Emerging Markets • Led the business to become the… Show more • Headed Commercial Operations for the region with a turnover of £5 bn. The region included Asia Pacific plus China, South Asia, Middle-East, Africa, CIS, Mexico & South America • Created a diversified business, organically and inorganically, moving from just being an Innovative Brand Company to include Classic Brands & Dermatology Highlights • In two years, achieved sales growth of 50% and a trading profit growth of 47% within Emerging Markets • Led the business to become the fastest growing company in Emerging Markets; becoming 4th largest pharmaceutical company in the region in 2010 from 5th a year earlier • Spearheaded the integration of Stiefel, a leading dermatology company and Viiv, a Joint Venture between Pfizer and GSK. Both ventures exceeded delivery within the first complete year of operation • Developed a Senior Level In-Country Organization which delivered on the strategy three years in a row Show less

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Area Head & General Manager, Australia, New Zealand & Pacific Islands
      • 2007 - 2008

      Sydney, Australia Headed the pharmaceutical business for Abbott in Australia and New Zealand, a business with a turnover ~ $300Mn, over 200 employees and a diversified product portfolio including Specialty Products, Primary Care Products and Consumer Products Highlights: • Grew the business at 9% against the market rate of 5% • Turned around the business by restructuring, reprioritizing and investing appropriately to maximize the Return on Investment. Previous year’s growth was ~2% • Built a… Show more Headed the pharmaceutical business for Abbott in Australia and New Zealand, a business with a turnover ~ $300Mn, over 200 employees and a diversified product portfolio including Specialty Products, Primary Care Products and Consumer Products Highlights: • Grew the business at 9% against the market rate of 5% • Turned around the business by restructuring, reprioritizing and investing appropriately to maximize the Return on Investment. Previous year’s growth was ~2% • Built a Vision for the organization with a detailed 5 year roadmap which included new product launches, influencing market growth and taking market share from competition • Moved Abbott up the ranks to become top 5 fastest growing companies in the pharma industry

    • General Manager, Korea
      • 2005 - 2007

      Headed the pharmaceutical business for Abbott in Korea, a $100Mn business with ~ 200 employees and a diversified product portfolio of Primary Care, Specialty and third part business Highlights • Instrumental in turning around the business from a declining enterprise in 2005 to 25% growth in 2007; convinced management to deepen its investment into the business which resulted in an ROI of 60% • Built a talent pipeline and groomed a local manager to take over as General Manager in… Show more Headed the pharmaceutical business for Abbott in Korea, a $100Mn business with ~ 200 employees and a diversified product portfolio of Primary Care, Specialty and third part business Highlights • Instrumental in turning around the business from a declining enterprise in 2005 to 25% growth in 2007; convinced management to deepen its investment into the business which resulted in an ROI of 60% • Built a talent pipeline and groomed a local manager to take over as General Manager in 2008, its first local head in 20 years • Launched various initiatives and programs which enabled Abbott Korea to be nominated as #1 employer in Korea in 2007

    • Director, Antivirals
      • 2004 - 2005

      Greater Chicago Area • Led ~$700Mn HIV franchise, in addition to managing sales in North America, Europe, Latin America, Asia-Pacific and Japan • Identified markets for expansion including China, Russia, and Mexico which led to double-digit growth for the franchise despite single digit market growth • Spearheaded creation of Short, Mid and Long-Term strategic plans for the brand which formed the basis for clinical, scientific, medical and marketing developments and programs • Collaborated with Research &… Show more • Led ~$700Mn HIV franchise, in addition to managing sales in North America, Europe, Latin America, Asia-Pacific and Japan • Identified markets for expansion including China, Russia, and Mexico which led to double-digit growth for the franchise despite single digit market growth • Spearheaded creation of Short, Mid and Long-Term strategic plans for the brand which formed the basis for clinical, scientific, medical and marketing developments and programs • Collaborated with Research & Development to develop a Life Cycle for HIV products

    • Chemical Manufacturing
    • 700 & Above Employee
    • Director, Global Strategic Marketing
      • Jun 2002 - Apr 2004

      Germany & USA • Led the global Hemophilia franchise for the company • Responsible for global Marketing and Communication strategy, Life Cycle Management for the franchise, sales force deployment and excellence, and Market Research • Collaborated and led cross-functional teams from around the world to ensure alignment and consistency

Education

  • Thunderbird School of Global Management
    Master of Business Administration (M.B.A.)

Community

You need to have a working account to view this content. Click here to join now